-
Start Preamble
Start Printed Page 20731
By Notice dated November 18, 2005, and published in the Federal Register on November 29, 2005, (70 FR 71559), Dade Behring Inc., Regulatory Affairs, Quality Systems, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:
Drug Schedule Tetrahydrocannabionols (7370) I Benzoylecgonine (9180) II Morphine (9300) II The company plans to produce the listed controlled substances in bulk to be used in the manufacturer of reagents and drug calibrator/controls for DEA exempt products.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Dade Behring Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Dade Behring Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Start SignatureDated: April 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E6-5962 Filed 4-20-06; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/21/2006
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- E6-5962
- Pages:
- 20731-20731 (1 pages)
- PDF File:
- e6-5962.pdf